Phensuximide: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
CSV import
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Short description|An anticonvulsant medication used in the treatment of epilepsy}}
{{Short description|An anticonvulsant medication}}
{{Drugbox
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477002276
| IUPAC_name = 1-Methyl-3-phenylpyrrolidine-2,5-dione
| image = Phensuximide.svg
| image = Phensuximide.svg
| image_size = 200px
| image_size = 200px
Line 6: Line 9:
}}
}}


'''Phensuximide''' is a medication used primarily in the management of [[epilepsy]], specifically for the treatment of [[absence seizures]]. It belongs to the class of drugs known as [[succinimides]], which are used to control seizures by reducing abnormal electrical activity in the brain.
'''Phensuximide''' is a [[medication]] used primarily in the treatment of [[epilepsy]], specifically for [[absence seizures]]. It belongs to the class of [[succinimides]], which are known for their effectiveness in managing certain types of seizures.


==Pharmacology==
==Pharmacology==
Phensuximide works by modulating the activity of [[calcium channels]] in the [[central nervous system]]. This action helps to stabilize neuronal membranes and prevent the spread of seizure activity. As a member of the succinimide class, it shares a similar mechanism of action with other drugs such as [[ethosuximide]].
Phensuximide works by reducing abnormal electrical activity in the brain. It is believed to modulate the activity of [[calcium channels]] in the [[thalamus]], a region of the brain that plays a key role in the generation of absence seizures. By stabilizing the neuronal activity, phensuximide helps to prevent the occurrence of seizures.


==Clinical Use==
==Medical Uses==
Phensuximide is indicated for the treatment of absence seizures, which are characterized by brief, sudden lapses in attention and activity. These seizures are most commonly seen in children and can interfere with learning and daily activities. Phensuximide is often used when other medications, such as ethosuximide, are not effective or cause unacceptable side effects.
Phensuximide is primarily indicated for the control of absence seizures, also known as [[petit mal seizures]]. These seizures are characterized by brief, sudden lapses in attention and activity, often without any warning. Phensuximide is typically used when other medications, such as [[ethosuximide]], are not effective or cause unacceptable side effects.


==Side Effects==
==Side Effects==
Common side effects of phensuximide include [[drowsiness]], [[dizziness]], and [[gastrointestinal disturbances]] such as [[nausea]] and [[vomiting]]. More serious side effects can include [[blood dyscrasias]], such as [[leukopenia]] and [[thrombocytopenia]], as well as [[liver toxicity]]. Patients taking phensuximide should be monitored regularly for these potential adverse effects.
Common side effects of phensuximide include [[gastrointestinal disturbances]] such as nausea and vomiting, as well as [[drowsiness]] and [[dizziness]]. In some cases, it may cause more serious side effects, including [[blood dyscrasias]] and [[liver toxicity]]. Patients taking phensuximide should be monitored regularly for any adverse effects.


==Chemical Properties==
==Mechanism of Action==
Phensuximide is chemically classified as a succinimide derivative. Its chemical structure is similar to that of other anticonvulsants in its class, featuring a succinimide ring. The structural formula of phensuximide is depicted in the accompanying image.
[[File:Phensuximide.svg|thumb|right|Structural formula of Phensuximide]]
Phensuximide's mechanism of action involves the inhibition of T-type calcium channels in the thalamic neurons. This inhibition reduces the pacemaker current that is responsible for generating the rhythmic cortical discharge associated with absence seizures. By dampening this activity, phensuximide helps to prevent the occurrence of seizures.


==History==
==History==
Phensuximide was developed as part of efforts to find effective treatments for epilepsy, particularly for types of seizures that were not well-controlled by existing medications. It was introduced into clinical practice in the mid-20th century and has since been used as an alternative to other anticonvulsants.
Phensuximide was developed as part of a series of succinimide derivatives aimed at improving the treatment of absence seizures. It was introduced as an alternative to other anticonvulsants with the goal of providing effective seizure control with fewer side effects.


==Related pages==
==Related Compounds==
Phensuximide is chemically related to other succinimide anticonvulsants, such as [[ethosuximide]] and [[methsuximide]]. These compounds share a similar mechanism of action and are used in the treatment of absence seizures.
 
==Related Pages==
* [[Epilepsy]]
* [[Epilepsy]]
* [[Anticonvulsant]]
* [[Calcium channel]]
* [[Absence seizure]]
* [[Absence seizure]]
* [[Ethosuximide]]
* [[Anticonvulsant]]


[[Category:Anticonvulsants]]
[[Category:Anticonvulsants]]
[[Category:Succinimides]]
[[Category:Succinimides]]
[[Category:Epilepsy treatment]]

Latest revision as of 11:39, 23 March 2025

An anticonvulsant medication


Phensuximide
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Phensuximide is a medication used primarily in the treatment of epilepsy, specifically for absence seizures. It belongs to the class of succinimides, which are known for their effectiveness in managing certain types of seizures.

Pharmacology[edit]

Phensuximide works by reducing abnormal electrical activity in the brain. It is believed to modulate the activity of calcium channels in the thalamus, a region of the brain that plays a key role in the generation of absence seizures. By stabilizing the neuronal activity, phensuximide helps to prevent the occurrence of seizures.

Medical Uses[edit]

Phensuximide is primarily indicated for the control of absence seizures, also known as petit mal seizures. These seizures are characterized by brief, sudden lapses in attention and activity, often without any warning. Phensuximide is typically used when other medications, such as ethosuximide, are not effective or cause unacceptable side effects.

Side Effects[edit]

Common side effects of phensuximide include gastrointestinal disturbances such as nausea and vomiting, as well as drowsiness and dizziness. In some cases, it may cause more serious side effects, including blood dyscrasias and liver toxicity. Patients taking phensuximide should be monitored regularly for any adverse effects.

Mechanism of Action[edit]

Structural formula of Phensuximide

Phensuximide's mechanism of action involves the inhibition of T-type calcium channels in the thalamic neurons. This inhibition reduces the pacemaker current that is responsible for generating the rhythmic cortical discharge associated with absence seizures. By dampening this activity, phensuximide helps to prevent the occurrence of seizures.

History[edit]

Phensuximide was developed as part of a series of succinimide derivatives aimed at improving the treatment of absence seizures. It was introduced as an alternative to other anticonvulsants with the goal of providing effective seizure control with fewer side effects.

Related Compounds[edit]

Phensuximide is chemically related to other succinimide anticonvulsants, such as ethosuximide and methsuximide. These compounds share a similar mechanism of action and are used in the treatment of absence seizures.

Related Pages[edit]